Conferences and Events

Conferences and Events

ASCO 2018
June 1-5, 2018
Chicago, IL

The VieCure team looks forward to attending ASCO 2018 in Chicago to share how our cognitive computing platform turns data into knowledge with comprehensive, personalized cancer treatment plans. 

We will be hosting our meetings at the Waldorf Astoria. To arrange a meeting with the VieCure team, please email

Cognitive Computing Keeps Cancer Patients Out of the ER

Cognitive Computing Keeps Cancer Patients Out of the ER

Intelligent mobile app will improve communications between cancer patients and providers and reduce ER visits.

Nonadherence to treatment plans is estimated to account for as much as 50 percent of treatment failures overall, and even for cancer patients, whose lives are on the line, adherence can be as low as 14 percent. Technology can help head-off these negative outcomes.

Cancer patients become overwhelmed. The complexity and volume of daily medications and symptom monitoring, while they are experiencing life-altering emotional and physical changes, is the perfect setup for mistakes, oversights, stress and hopelessness. Intelligent mobile technology can break these daily tasks into bite-size pieces and deliver them at the right time, relieving a patient’s responsibility to constantly monitor all facets of their care. 

CMS decision transformative for cancer care

CMS decision transformative for cancer care

The Centers for Medicare & Medicaid Services’ (CMS) decision to reimburse for Next Generation Sequencing (NGS) for patients with advanced cancer is a major step to realizing personalized cancer treatment. This reimbursement approval fits perfectly with the expanding use of VieCure’s comprehensive platform for precision cancer care that optimally utilizes NGS within its proprietary VCureEyellation AI engine.   

Genomics-based research is advancing quickly, that makes it difficult for cancer practitioners to keep up.  The basis of precision, or personalized, medicine is understanding the unique cellular mutations that are driving each person’s cancer.  NGS is a major step forward to know a cancer patient’s unique type of cancer.  Medicare has recognized that knowing the drivers of each person’s cancer is beneficial to treating advanced stage cancers.  VieCure uses sequencing data to generate personalized and comprehensive care plans curated by the world’s top research scientists.  Reimbursement by Medicare will continue the path of broad adoption of NGS and precision care.

Bundle Blocks 2

Knowledge-Based Comprehensive Cancer Care

Generate and manage comprehensive, personalized care plans in real time with our cognitive computing platform.

Cognitive computing is the use of computers to simulate expert thinking.

Our VCureEyellation inference engine combines patient-specific data with expert codified knowledge to create and manage personalized and actionable treatment plans based on nationally and internationally-accepted standards of care including the latest genomic-based considerations where and when appropriate.

Bundle Blocks 1

Cognitive Computing Platform

VieCure unveils its cognitive computing platform with codified expert knowledge and real-time comprehensive and personalized care plans.  Our VCureEyellation inference engine combines data, knowledge and technology to support optimal and personalized care in seconds.

We codified knowledge in nationally and internationally-recognized standards including genomic-based targeted therapies, immunotherapies and complex combination treatments.

Our 21st century platform facilitates clinical peer-to-peer knowledge transfer where physicians get immediate access to up to date standards of care tempered with expert knowledge based on the genomic make up of the patient’s cancer, where appropriate.

Clinicians access current expert clinical knowledge, in real time, to create and actively manage patient-specific treatment plans that consider patient history, co-morbidities and genomic-guided considerations. Patient-reported medication and toxicity tracking allows clinicians to monitor and proactively manage side effects and symptoms remotely and in real-time.

Baptist Health to Improve Cancer Care with VCurePrecision™ Cognitive Computing Platform

MONTGOMERY, AL (March 5, 2018) (VieCure and related products are the property of Viviphi Ltd) VieCure and Baptist Health announced today that the VCurePrecision platform will be deployed across the central Alabama cancer network, offering personalized cancer treatment to an estimated 4,000 patients annually throughout the region.  

Baptist Health is a 689-licensed-bed and accredited health system in Montgomery and is the largest provider of cancer services in central Alabama. They have committed to advancing the care offered to cancer and hematology patients through the cognitive computing platform developed by VieCure.   

The VCurePrecision platform allows clinicians to generate and manage comprehensive, personalized care plans in real time. Powered by the VCureEyellation inference engine, the platform combines patient-specific data with expert codified knowledge to create and manage personalized and actionable treatment plans based on nationally and internationally-accepted standards of care, including the latest genomic-based considerations where and when appropriate.

VieCure and Avera Health Confirm Clinical Validation and System-Wide Implementation of Cognitive Computing Platform

VieCure and Avera Health announced that the VieCure's cognitive computing platform will be fully implemented across the multi-state cancer system. The platform was developed through a clinical collaboration between the two organizations.

VCurePrecision is a cognitive computing platform that generates and manages comprehensive, personalized treatment plans in seconds.

The VCureEyellation inference engine platform combines patient-specific data from the electronic medical record (EMR) with genomic tumor information (when available) to generate personalized treatment plans that comply with nationally and internationally recognized standards of care while considering the latest in genomic based precision medicine where appropriate.

Bundle Blocks 2

Patient Engagement Mobile App

Our patient mobile app empowers patients to actively participate in managing their care and communication with their care team.

  • Mobile medication tracking and event reminders
  • Easy and timely communication with care team
  • Self-manage care and side effects management
  • Education about interventions and expectations for symptoms

Our mobile app facilitates engagement between patients and their care team and provides patients with easy access to  important details for current treatment and ongoing survivorship needs.

Matt's Story

Matt is a lung cancer survivor (8 years and counting) because of genomic testing and a personalized treatment strategy.

As the Founder/CEO of SURVIVEiT®, he believes it is vital for patients to take control of their care and develop a treatment plan that is specific to their cancer.

Learn more about Matt’s personal battle with cancer and his passion for helping patients to advocate for the best care available.

Know What is Driving Your Cancer

Dr. Brian Leyland-Jones explains why each cancer patient must insist on having his or her tumor sequenced to find out what genetic alterations are driving his or her cancer.

When you know the genomics behind your cancer and the treatments available, you can work with your doctor to determine a treatment strategy specific to you.

VieCure News